Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ASP0739 |
Synonyms | |
Therapy Description |
ASP0739 are human artificial adjuvant vector cells loaded with the CD1d ligand alpha-galactosylceramide and modified to express the tumor associated antigen NY-ESO-1 (CTAG1B), which potentially induce activation of immune cells, and cytotoxic T-cell mediated response against tumor cells expressing NY-ESO-1 (NCI Thesaurus). |